Listen in as a doctor and a person with diabetes chat about new diabetes science. Cohosts Neil S. Skolnik, MD, professor of family and consumer medicine, Temple University School of Medicine, associate director, family medicine residency program, Abington Memorial Hospital, and Kelly Rawlings, PWD, editorial director of Diabetes Forecast magazine, discuss highlights from the American Diabetes Association's professional scientific journals.
Compared with short-acting sulfonylureas—a common treatment for type 2 diabetes—long-acting sulfonylureas have a higher risk of low blood glucose. The...
The first study we’ll discuss looks at some of the challenges to taking medication as directed. The second is an update of blood pressure management r...
In today’s busy world, information can come at you from so many sources—news reports, social media, magazine articles. And advertisements. When it com...
Brand-new information shared at the American Diabetes Association’s recent Scientific Sessions about SGLT2-inhibitors and unprecedented protection for...
The final episode of our series about type 2 diabetes medications focuses on an injectable medication that’s been around the longest—since the early 1...
The second episode of our series about type 2 diabetes medications features prescription drugs that can be used when a single medication isn’t enough ...
This is the first installment of a three-part series about type 2 diabetes medications. There are nine classes of diabetes drugs that, along with heal...
Listeners, you are probably aware of the two main types of diabetes, type 1 (an autoimmune disorder) and type 2 (a metabolic disorder). Today we’re go...
We have two studies for you about hypoglycemia, or low blood glucose. As you know, hypoglycemia is a risk with certain diabetes medications and someth...